These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 1399405)
1. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model. Oguz H; Ozbilge H; Oguz E; Gurkan T Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996 [TBL] [Abstract][Full Text] [Related]
4. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659 [TBL] [Abstract][Full Text] [Related]
5. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis. Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004 [TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Callegan MC; Engel LS; Hill JM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714 [TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Callegan MC; Hill JM; Insler MS; Hobden JA; O'Callaghan RJ Curr Eye Res; 1992 Nov; 11(11):1111-9. PubMed ID: 1483341 [TBL] [Abstract][Full Text] [Related]
10. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy. Sharma V; Sharma S; Garg P; Rao GN Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319 [TBL] [Abstract][Full Text] [Related]
11. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293 [TBL] [Abstract][Full Text] [Related]
12. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis. Lauffenburger MD; Cohen KL Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis. Dajcs JJ; Moreau JM; Thibodeaux BA; Traidej M; Austin MS; Marquart ME; Stroman DW; O'Callaghan RJ Cornea; 2001 Nov; 20(8):878-80. PubMed ID: 11685070 [TBL] [Abstract][Full Text] [Related]
15. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus corneal virulence in a new topical model of infection. Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535 [TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis. Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987 [TBL] [Abstract][Full Text] [Related]
20. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits. Oksuz H; Duran N; Tamer C; Cetin M; Silici S Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]